O Donnell Financial Services, LLC 9 Meters Biopharma, Inc. Transaction History

O Donnell Financial Services, LLC

  • $212 Million
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 26, 2022
BUY
$0.21 - $0.32 $357 - $544
1,700 Added 0.19%
878,171 $189,000
Q2 2022

Jul 27, 2022
BUY
$0.26 - $0.64 $5,744 - $14,141
22,096 Added 2.59%
876,471 $229,000
Q1 2022

May 04, 2022
BUY
$0.52 - $1.0 $908 - $1,747
1,747 Added 0.2%
854,375 $512,000
Q4 2021

Feb 02, 2022
BUY
$0.85 - $1.33 $10,115 - $15,828
11,901 Added 1.42%
852,628 $629,000
Q3 2021

Oct 29, 2021
BUY
$1.03 - $1.41 $865,948 - $1.19 Million
840,727 New
840,727 $1.09 Million

Others Institutions Holding NMTR

# of Institutions
3
Shares Held
67.9K
Call Options Held
0
Put Options Held
0
View Full List

About 9 METERS BIOPHARMA, INC.

NMTR Quotes by TradingView
  • Ticker NMTR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 12,955,400
  • Market Cap $259K
  • Description
  • 9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease, as we...
More about NMTR
Track This Portfolio

Track O Donnell Financial Services, LLC Portfolio

Follow O Donnell Financial Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of O Donnell Financial Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on O Donnell Financial Services, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email